AAAlan Askari

Alan Askari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alan Askari has a total of 297 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew Currie

    Surgical Epidemiology, Trials and Outcome Centre (SETOC), St Mark's Hospital & Academic Institute, Harrow, Middlesex, HA1 3UJ, United Kingdom

    9 shared publications
  • Ali Kordzadeh

    Department of Vascular, Endovascular and Renal Access Surgery, Mid & South Essex NHS Foundation Trust, Basildon Hospital, Nether Mayne, Basildon SS16 5NL, Essex, UK

    8 shared publications
  • Omar Faiz

    Surgical Epidemiology, Trials and Outcome Centre (SETOC) St Mark′s Hospital Harrow UK

    8 shared publications
  • Aruna Munasinghe

    Department of General Surgery, Luton & Dunstable Hospital , Luton , UK

    7 shared publications
  • Subramanian Nachiappan

    St Mark's Hospital & Academic Institute, London, UK

    7 shared publications
  • Vigyan Jain

    Department of General Surgery, Luton & Dunstable Hospital , Luton , UK

    7 shared publications

Latest Publications

  • Open Access

    The Effect of Increased Sodium Intake with a Carbohydrate-Rich Meal on Glucose Homeostasis in People without Diabetes after Roux-en-Y Gastric Bypass: a Proof-of-Concept, Randomized, Open-Label, Crossover Study

    by Stanislava Katsarova–Harrison, Gráinne Whelehan, Joseph Henson, Louisa Y. Herring, David Bowrey, Alice E. Thackray, David J. Stensel, Iskander Idris, Oluwaseun Anyiam, Anjali Zalin, et al.

    Introduction: Roux-en-Y gastric bypass (RYGB) induces substantial weight loss and changes in glucose homeostasis, partly through alterations in gastrointestinal anatomy and nutrient absorption. Sodium-glucose co-transporters-1 (SGLT-1) facilitate intestinal glucose absorption, a process that may be compromised post-RYGB. Animal studies suggest that sodium supplementation to a meal may enhance SGLT-1 activity post-RYGB. In this study, we investigated whether adding sodium chloride (NaCl) to a carbohydrate-rich meal affects glucose homeostasis in people after RYGB. Methods: In this open-label, randomized, crossover study, eleven adults without diabetes post-RYGB (mean age 57.3 ± 11.3 years, BMI 35.1 ± 7.5 kg/m2, 64% female) underwent two mixed meal tolerance tests (MMTT), on separate days, either with or without 2 g of additional NaCl (785 mg sodium). The primary outcome was the difference in nadir postprandial plasma glucose between conditions. Secondary outcomes included differences in area under the curve (AUC 0 − 180‘ ), fasting and peak plasma glucose, insulin, c-peptide and glucagon-like peptide-1 (GLP-1) concentrations. Results: The addition of 2 g NaCl did not alter nadir plasma glucose (3.7 mmol/L with NaCl vs 3.5 mmol/L without NaCl, 95% CI: -0.50 to 0.30, p = 0.55), fasting glucose or AUC 0 − 180’ glucose. However, peak plasma glucose was lower with NaCl (7.8 vs 8.3 mmol/L, 95% CI: -0.88 to -0.08, p = 0.02). No differences were observed in AUC 0 − 180’ , fasting and peak insulin, c-peptide and GLP-1 concentrations between the conditions. Conclusions: In individuals post-RYGB without diabetes, sodium supplementation during a carbohydrate-rich meal did not substantially affect glucose homeostasis, although it appeared to reduce peak postprandial plasma glucose. Further studies are warranted to explore the clinical relevance of this effect.


  • Open Access

    Clinical Outcomes of Passive Sensors in Remote Monitoring: A Systematic Review

    by Essam Rama, Sharukh Zuberi, Mohamed Aly, Alan Askari, Fahad M. Iqbal

    Remote monitoring technologies have transformed healthcare delivery by enabling the in-home management of chronic conditions, improving patient autonomy, and supporting clinical oversight. Passive sensing, a subset of remote monitoring, facilitates unobtrusive, real-time data collection without active user engagement. Leveraging devices such as smartphones, wearables, and smart home sensors, these technologies offer advantages over traditional self-reports and intermittent evaluations by capturing behavioural, physiological, and environmental metrics. This systematic review evaluates the clinical utility of passive sensing technologies used in remote monitoring, with a specific emphasis on their impact on clinical outcomes and feasibility in real-world healthcare settings. A PRISMA-guided search identified 26 studies addressing conditions such as Parkinson’s disease, dementia, cancer, cardiopulmonary disorders, and musculoskeletal issues. Findings demonstrated significant correlations between sensor-derived metrics and clinical assessments, validating their potential as digital biomarkers. These technologies demonstrated feasibility and ecological validity in capturing continuous, real-world health data and offer a unified framework for enhancing patient care through three main applications: monitoring chronic disease progression, detecting acute health deterioration, and supporting therapeutic interventions. For example, these technologies successfully identified gait speed changes in Parkinson’s disease, tracked symptom fluctuations in cancer patients, and provided real-time alerts for acute events such as heart failure decompensation. Challenges included long-term adherence, scalability, data integration, security, and ownership. Future research should prioritise validation across diverse settings, long-term impact assessment, and integration into clinical workflows to maximise their utility.


  • Disparities in Complication Rates Among Ethnic Minorities Undergoing Bariatric Surgery in the UK

    by Mohamed Aly, Fahad Iqbal, Aruna Munasinghe, Omer Al-Taan, Richard Welbourn, Omar Khan, Chanpreet Arhi, Alan Askari

    Background Ethnicity may play a significant role in determining surgical outcomes. This study examines the disease profiles across ethnic groups and investigates whether ethnicity influences the risk of complications following bariatric surgery. Methods Data from the United Kingdom’s National Bariatric Surgery Registry (NBSR) were analysed, encompassing all adult patients undergoing bariatric procedures. Comparative analyses were performed, and a multivariable regression model was developed to identify factors associated with postoperative complications. Results A total of 77,710 (78.8% female) patients were included in the analysis, with a median age of 46 (IQR 37–55) years. Most patients were Caucasian (91.6%), followed by Asian (4.1%), Afro-Caribbean (2.5%), and African (1.7%) groups. Afro-Caribbean patients had the highest median BMI (44.5 kg/m2) and the highest prevalence of hypertension (43.2%), while Asian patients were younger (median age 41 years) and had a higher prevalence of diabetes mellitus (29.1%). African and Afro-Caribbean patients were less likely to self-fund their procedures (14.9% and 10.6%, respectively) compared to Caucasians (25.9%). Complication rates were the highest among Afro-Caribbean patients (5.8 vs 4.8%, p < 0.001) compared to Caucasians. Multivariable regression analysis identified ethnicity as an independent predictor of postoperative complications, with Afro-Caribbean (OR 1.47, 95% CI 1.22–1.87, p < 0.001) and African (OR 1.34, 95% CI 1.05–1.70, p = 0.019) patients demonstrating significantly increased risks. Conclusions This registry analysis identified ethnic disparities in disease profiles and postoperative outcomes among bariatric surgery patients in the UK, underscoring the need for targeted health policies to improve outcomes in these vulnerable populations.


  • Open Access

    National Emergency Bariatric Surgical Audit (NEBSA): a protocol for a multi-center prospective study of unplanned interventions following emergency bariatric surgery

    by Fahad M. Iqbal, Alan Askari, Matthew J. Lee, Marianne Hollyman, Roxanna Zakeri, Dimitri J. Pournaras, Omar Al-Taan, Aruna Munasinghe, Aly Mohamed

    Introduction: The advent of bariatric surgery as a widespread intervention is paralleled by comprehensive data capture in bariatric registries following elective surgery. However, significant challenges hinder tracking the incidence and nature of severe complications in the context of bariatric surgery. As the prevalence of bariatric procedures escalates, the establishment of a dedicated, prospective complication registry becomes imperative. Such an initiative would facilitate a nuanced understanding of bariatric surgical emergency (BSE) within the current healthcare milieu, enhance economic evaluations, elucidate long-term patient outcomes, and inform requisite adjustments in professional training. This study is designed to capture and assess the ramifications of emergency bariatric surgical practices within the United Kingdom. Methods and analysis: We propose a prospective, multi-center, audit of emergency bariatric surgical activity in all UK hospitals. Eligible participants are those who undergo any intervention or procedure (surgical or endoscopic) to diagnose or treat BSE. Primary outcome measures will include hospital length of stay, rates of complications (Clavien–Dindo), and 30-D mortality. Secondary outcomes will assess the broader impacts and patterns of care, including variations in practice and resource utilization across the nation, rates of outpatient follow-up, and the frequency of subsequent procedures (surgical or endoscopic) post-BSE. Additionally, the study will investigate potential predictors for patients’ choice between state-funded and self-pay bariatric surgery options, considering factors such as ethnicity and previous engagement with NHS-specialized weight loss pathways. Ethics and dissemination: This study will be registered as clinical audit at each participating hospital. The protocol will be disseminated through the British Obesity and Metabolic Surgery Society network and using a targeted social media-based strategy in the UK.


  • Open Access

    National introduction of one-anastomosis gastric bypass in the UK National Bariatric Surgery Registry: a cohort study

    by Andrew C PhD FRCS Currie, Alan Askari, Chetan Parmar, James Byrne, Ahmed R. Ahmed, Chris M. Pring, Omar A. Khan, Peter K. Small, Kamal Mahawar

    Aim: There is a paucity of evidence regarding the national introduction of newer bariatric metabolic surgery procedures. This study assessed the impact of introducing one-anastomosis gastric bypass (OAGB) in bariatric surgical practice in the UK on 30-day postoperative morbidity and early postoperative weight loss. Methods: Patients who underwent primary BMS in the UK National Bariatric Surgical Registry (2010–2019) were identified. Patient characteristics, 30-day postoperative morbidity, and 12-month total body weight loss (TBWL) were also assessed. Multivariate regression was performed for associations between 30-day postoperative morbidity and 12-month TBWL, with SG as a reference. Learning effects were assessed by factoring in the institutional OAGB caseload (0–24/25–49/50+ cases). Results: A total of 59 226 patients underwent primary BMS during the study period (RYGB, 38 434; SG, 24 702; AGB, 12 627; OAGB, 3408; and others, 276). The 30-day postoperative morbidity was lower for OAGB 1.8% (51/2802) compared to RYGB 4.2% (1391/32 853) and SG 3.4% (725/21 333) but higher than AGB 1.2% (123/9915), while on multivariate regression, OAGB was associated with reduced morbidity once the institution caseload exceeded 50 operations (OR 0.35 (95% CI: 0.22–0.56; PP<0.001). Conclusion: OAGB has been safely implemented in UK national bariatric surgery practice. It has lower reported postoperative morbidity and comparable weight loss to RYGB or SG, despite being offered to patients with more severe and complex obesity.


  • Characterizing barriers and facilitators of metabolic bariatric surgery tourism: a systematic review

    by Sharukh Zuberi, Abdullah Egiz, Hasan Iqbal, Periyathambi Jambulingam, Douglas Whitelaw, Tanveer Adil, Vigyan Jain, Omar Al-Taan, Aruna Munasinghe, Alan Askari, et al.

    Background: Metabolic bariatric surgery tourism continues to rise and has become a growing concern for bariatric surgeons globally. With varying degrees of regulation, counselling and success, those that develop complications may have to deal with a multitude of challenges often distant from their country of operation. The aim of this study was to characterize the barriers and facilitators influencing individuals to undergo metabolic bariatric surgery tourism, in order to better understand the implications to the National Health Service and other healthcare systems. Methods: A systematic literature search, restricted to the English language, was performed to identify relevant studies. All studies were included until December 2022, the last search date. Study quality was assessed with the validated mixed-methods appraisal tool. A Braun and Clarke thematic analysis was undertaken to identify themes and subthemes. Results: A total of five studies met the inclusion criteria. Identified themes included: availability, accessibility, cost, eligibility, reputation, and stigma; the available evidence was of varying quality. Conclusion: This work identifies a series of subthemes influencing the decision to undertake metabolic bariatric surgery tourism. The results highlight the limited literature available in understanding the complex motivational insights; the scale of the problem in the current healthcare system; cost and long-term outcomes. A National Emergency Bariatric Surgery audit would allow generation of more robust data to explore further the issues of clinical relationships and networks and to guide policy making.


  • Systematic Review and Meta-analysis of the Effects of Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy on Dyslipidemia

    by Tanveer Adil, Minali Perera, Douglas Whitelaw, Periyathambi Jambulingam, Omer Al-Taan, Aruna Munasinghe, Farhan Rashid, Amjid Riaz, Vigyan Jain, Alan Askari

    The aim of this meta-analysis was to compare the effects of LRYGB and LSG on dyslipidemia. Studies comparing the effects of LRYGB and LSG on dyslipidemia with follow-up of 12 months or more were included. Twenty-four studies comprising seven RCTs and 17 comparative observational studies were included. Meta-analysis of RCTs (n=487) showed that improvement/resolution of dyslipidemia was better after LRYGB (68.5%, n=161/235) compared to LSG (48.4%, n=122/252). Patients undergoing LRYGB were more than twice as likely to experience improvement/resolution in dyslipidemia compared to those undergoing LSG (OR 2.28, 95% CI 1.21–4.29, p=0.010). Both LRGYB and LSG appears effective in improving dyslipidemia at >12 months after surgery; however, this improvement is more than twice higher after LRYGB compared to LSG.


  • Open Access

    Limitations concerning evaluation of the current guidelines using the Appraisal of Guidelines Research and Evaluation II

    by Paschalis Gavriilidis, Alan Askari, Efstratios Gavriilidis, Salomone Di Saverio, R. Justin Davies, Nicola De’angelis

    Limitations concerning evaluation of the current guidelines using the Appraisal of Guidelines Research and Evaluation II

  • Open Access

    The surgical management of obesity

    by Alan Askari, Periyathambi Jambulingam, Roy Gurprashad, Omer Al-Taan, Tanveer Adil, Aruna Munasinghe, Vigyan Jain, Farhan Rashid, Douglas Whitelaw

    Obesity has reached pandemic levels globally. Surgical management of obesity aims to establish metabolic control, weight loss and resolution of multiple health conditions and to improve quality of life. Here, we examine the role of surgery in the management of obesity within the context of a multidisciplinary team involving a variety of healthcare professionals. We highlight the importance of patient selection, perioperative care, the various types of bariatric surgery currently available as well as emerging procedures. In addition to clarifying the different types of procedure, we also examine the potential complications and issues of weight regain and failure to lose weight. Ultimately, bariatric surgery remains comparatively safe and with generally excellent results in terms of control of existing obesity-related conditions; with the ever-increasing number of patients living with obesity, the scope of bariatric surgery is thus likely to increase.


  • Association between preoperative glucose- lowering medication agents and the status of type 2 diabetes mellitus after bariatric surgery

    by Haseem Raja, Saarah Ebrahim, Ravikrishna Mamidanna, Krashna Patel, Alan Askari, Chanpreet Arhi, Aruna Munasinghe, Farhan Rashid, Omer Al-Taan, Periyathambi Jambulingam, et al.

    Introduction: Bariatric surgery is an effective treatment for type 2 diabetes mellitus (T2DM) in patients with morbid obesity. This study investigates whether duration of diabetes and anti-diabetes therapy are associated with glycaemic control after surgery in a routine clinical setting. Method: A cohort analysis of a prospectively maintained database was carried out for consecutive bariatric operations performed between April 2017 and March 2018 for patients with T2DM. Results: A total 105 patients with T2DM underwent bariatric surgery (89 Roux-en-Y gastric bypass and 16 sleeve gastrectomy). Median follow-up was 19 months ([interquartile range] IQR 13-24 months). Median weight and body mass index (BMI) on the day of surgery were 125 kg (IQR 103.9- 138.7) and 42.4 kg/m2 (IQR 39-46.8), respectively. At follow- up, 68 patients (64.8%) had achieved remission of diabetes. Patients who were pre-operatively on more than one glucose-lowering medication were less likely to go into remission (odds ratio [OR] 0.13, 95% CI 0.04-0.44, p=0.001) compared to those that were on a single glucose-lowering medication agent. Pre-operative use of insulin therapy (OR 0.09, 95% CI 0.03-0.31, p= Conclusions: Most patients who are medicated for T2DM can stop their glucose-lowering medication after bariatric surgery. Patients who are on multiple glucose-lowering medication agents or those dependent on insulin or SGLT2 inhibitors before bariatric surgery are less likely to undergo complete remission >12 months after bariatric surgery.